Inspire Medical reports Q4 EPS $1.15, consensus 72c

Reports Q4 revenue $239.72M, consensus $237.41M. “We are thrilled with our strong performance in the fourth quarter, growing revenue 25% year-over-year, delivering nearly $32 million in operating income and increasing diluted net income per share 135% year-over-year,” said Tim Herbert, chairman and CEO of Inspire Medical (INSP) Systems. “During the quarter, we made steady progress toward the full launch of Inspire V, optimized our leadership team to fuel future growth, continued to improve our profitability, initiated a $75 million accelerated share repurchase program and reached an important milestone with over 90,000 patients treated with Inspire therapy. We look forward to continuing our strong performance in 2025 aided by the launch of Inspire V,” concluded Herbert.